Physician profile
Mark W Kemp
NPI 1053365064
$1,198.20
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $825 · 2023: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $790.39 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $95.23 | 2021-2023 | Eliquis |
| Merck Sharp & Dohme LLC | $70.95 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.36 | 2021-2023 | |
| Amgen INC. | $44.65 | 2021-2023 | Repatha |
| Mylan Specialty L.P. | $31.59 | 2023 | Yupelri |
| Astellas Pharma US INC | $20.93 | 2023 | Myrbetriq |
| Pfizer INC. | $20.69 | 2022 | |
| Novo Nordisk INC | $17.04 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.36 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $15.13 | 2023 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kemp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.